Influence of itraconazole on antidiabetic effect of thiazolidinedione in diabetic rats

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn , Issue 1, 2009, Pages 119-124

  Janadri, Suresh ^a   Setty, S Ramachandra ^a   Kharya, M D ^b  

^a SCS College of Pharmacy   (India)

^b DR H S GOUR UNIVERSITY   (India)

Author keywords

Alloxan; Antidiabetic activity; Itraconazole; Pioglitazone; Rosiglitazone

Indexed keywords

ALLOXAN; ITRACONAZOLE; PIOGLITAZONE; ROSIGLITAZONE;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; FEMALE; GLUCOSE BLOOD LEVEL; MALE; NONHUMAN; RAT; TREATMENT DURATION;

EID: 77953458433     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. st Ed. BS Shah Prakashan Ahmedbad; 2004; 135-48.
2. Sunilkumar B, Lucia P, Miglani BD. Possible drug interactions in hospitalised patients. The Ind J Hos Pharm 1998; 91-93.
3. th Ed. Megraw Hill, NewYork; 2001: 45-65.
4. Yuan R et al. In vitro studies; experience of the food and drug administration. Clin. Pharmacol. Ther.1999; 66:9-15.
5. Sahi J, Black CB, Hamilton GA, Zheng X, Jolley S, Rose KA, Gilbert D. Comparative effects of thiazolidinediones used for treatment of non-insulin dependent diabetes mellitus. Drug Metab Dispos 2003; 31(4): 439-46.
6. Vanden Bossche H et al. Cytochrome P-450: target for itraconazole. Drug. Dev. Res. 1986; 8:287.
7. Vanden Bossche H, Marichal P. and Le Jeune L. Effects of itraconazole on cytochrome P-450 dependent sterol 14 demethylation and reduction of 3-Ketosteriods in crytococeus reoformans. Antimicrob Ag Chomother 1993; 37: 2101.
8. N.S. Chauhan, V.K. Dixit. Antihyperglycemic activity of the ethanolic extract of Curculigo orchioides Gaertn. Pharmacognosy Magazine.2007; 3(12), 237-240.
9. S.Venkatesh, G.Dayanand. Reddy, B. Madhava, M. Ramesh, Appa.A.V.N. Rao, Antihyperglycemic activity of Caralluma attenuata. Fitoterpia. 2003; 74:274-279.
10. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen reptor. Ann Clin Biochem, 1969, 6:24-7.
11. Ramachandra SS et al. Influence of Itraconazole on sulfonylureas-induced hypoglycemia in diabetic rats. Ind J Pharma Sci 2005; 67(6): 677-680.
12. Rydberg T, Jonsson A, Karlsson MO and Melander A. Concentration-effect relations of glibenclamide and its active metabolites in man: modeling of Pharmacokinetics and pharmacodynamics. Br J Clin Pharmacol 1997; 43:373-81.
13. Kantola, Teemu, Kivistoe, Kari T, Neuvonen, Pertti J. Effect of itraconazole on the pharmacokinetics of atorvastatin. Clin Pharmacol Tehr 1998; 64(1):58-65.
14. Brian WR. Hypoglycemic agents, In: Levy RH, Thummel KE, Tranger WF, Haunsten PD, Eichelbaum M, eds. Metabolic drug interactions. Philadelphia: Lippincott Williams & Wilkins; 2000. 429-43.
15. Kidd RS, Straughn AB and Meyer MC. Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele. Pharmacogenetics 1999; 9:71-80.
16. Back DJ, Tjia JF. Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporine by human liver microsomes. Brit J Pharmacol 1991; 32: 624.